ArticlePharmaceuticals (Basel, Switzerland)2025

Comparative Safety of Empirical Antibiotic Classes in Newly Hospitalized COVID-19 Patients.

Kalynn Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.